BIND Therapeutics, Inc (BIND) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 19 transactions totaling $2.8M, demonstrating a bullish sentiment with $2.8M in net insider flow. The most recent transaction on Aug 29, 2016 involved a transaction of 15,000 shares valued at $6.6K.
No significant insider buying has been recorded for BIND in the recent period.
No significant insider selling has been recorded for BIND in the recent period.
Based on recent SEC filings, insider sentiment for BIND is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BIND Therapeutics, Inc (BIND) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading BIND stock, having executed 19 transactions in the past 90 days. The most active insider is Rusnano (Executive), who has made 2 transactions totaling $1.8M.
Get notified when executives and directors at BIND file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 29, 2016 | Barton Hutt Peter | Executive | Option Exercise | 15,000 | $0.44 | $6.6K | |
| Aug 29, 2016 | K. Rowinsky Eric | Executive | Option Exercise | 15,000 | $0.44 | $6.6K | |
| Aug 26, 2016 | Langer Robert | Executive | Option Exercise | 15,000 | $0.44 | $6.6K | |
| Aug 26, 2016 | Lynch Daniel | Executive | Option Exercise | 20,000 | $0.44 | $8.8K | |
| Aug 26, 2016 | A. Rowland Charles Jr | Executive | Option Exercise | 15,000 | $0.44 | $6.6K | |
| Aug 26, 2016 | Tzianabos Arthur | Executive | Option Exercise | 15,000 | $0.44 | $6.6K | |
| Dec 30, 2014 | Minick Scott | Executive | Gift | 500 | $N/A | $0 | |
| Sep 11, 2014 | Minick Scott | Executive | Other | 161 | $N/A | $0 | |
| Sep 9, 2014 | Minick Scott | Executive | Gift | 1,100 | $N/A | $0 | |
| Aug 20, 2014 | Minick Scott | Executive | Other | 161 | $N/A | $0 | |
| Jul 8, 2014 | Minick Scott | Executive | Other | 160 | $N/A | $0 | |
| Sep 25, 2013 | Rusnano | Executive | Conversion | 1,053,291 | $N/A | $0 | |
| Sep 25, 2013 | Rusnano | Executive | Purchase | 120,000 | $15.00 | $1.8M | Large |
| Sep 25, 2013 | Afeyan Noubar | Executive | Purchase | 20,000 | $15.00 | $300.0K | |
| Sep 25, 2013 | Afeyan Noubar | Executive | Conversion | 1,542,616 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 4 | $2.8M | 98.5% |
Exercise(M) | 6 | $41.8K | 1.5% |
Gift(G) | 2 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Conversion(C) | 4 | $0 | 0.0% |
Insiders at BIND Therapeutics, Inc are accumulating shares at an accelerated pace. With 11 insiders making 19 transactions totaling $2.8M in purchases versus $0 in sales, the net buying activity of $2.8M signals strong executive confidence. Rusnano (Executive) leads the buying activity with $1.8M in transactions across all time.